| PF-670462 free base | IC50 | 13.0 [1] |
| 3-[(2,4,6-Trimethoxyphenyl)methylidene]-1H-indol-2-one | IC50 | 1000.0 [1], 2570.0 [2] |
| 3-[(3-Chlorophenoxy)methyl]-1-(Tetrahydro-2h-Pyran-4-Yl)-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine | IC50 | 32.0 [1], 711.0 [2] |
| 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 120.0 [1], 124.0 [2] |
| CK1 Inhibitor | IC50 | 300.0 [1] |
| Bischof-5 | IC50 | 22.0 [1], 42.0 [2] |
| [(4-{2-[(3-Hydroxyphenyl)amino]-1h-Benzimidazol-1-Yl}-1,3,5-Triazin-2-Yl)amino]acetonitrile | IC50 | 16000.0 [1], 40000.0 [2] |
| 4-[1-Methyl-3-(4-fluorophenyl)-1H-pyrazole-4-yl]pyridine | IC50 | 48.1 [1], 545.0 [2] |
| 3-[4-[3-(4-Fluorophenyl)-1-methylpyrazol-4-yl]pyridin-2-yl]morpholine | IC50 | 6.6 [1], 90.0 [2] |
| 9-[3-(4-Fluorophenyl)-1-Methyl-1h-Pyrazol-4-Yl]-2,3,4,5-Tetrahydropyrido[2,3-F][1,4]oxazepine | IC50 | 6.0 [1], 42.1 [2] |
| 1-{4-[3-(4-Fluorophenyl)-1-Methyl-1h-Pyrazol-4-Yl]pyridin-2-Yl}-N-Methylmethanamine | IC50 | 12.9 [1], 63.8 [2] |
| 4-[1-Methyl-3-(4-fluorophenyl)-1H-pyrazole-4-yl]pyridine-2-methanol | IC50 | 14.2 [1], 237.0 [2] |
| Harmine | IC50 | 1500.0 [1] |
| 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 188.0 [1] |
| 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 41.0 [1] |
| 1,4-Dihydroxyanthraquinone | IC50 | 40000.0 [1] |
| N3-(4-Fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine | IC50 | 510.0 [1] |
| Hymenialdisine | IC50 | 35.0 [1] |
| 3-[(2,4,6-Trimethoxy-phenyl)-methylene]-indolin-2-one | IC50 | 1000.0 [1] |
| 1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 170.0 [1] |
| (3Z)-3-[(2,4,6-Trimethoxyphenyl)methylidene]-1H-indol-2-one | IC50 | 700.0 [1] |
| 1,4-Diaminoanthraquinone | IC50 | 330.0 [1] |
| CID 46209401 | IC50 | 10000.0 [1] |
| 1-Amino-4-hydroxyanthraquinone | IC50 | 660.0 [1] |
| 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 150.0 [1] |
| JNK Inhibitor VIII | Ki | 7800.0 [1] |
| N-(1,3-Benzothiazol-2-yl)-2-phenylacetamide | IC50 | 330.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-morpholin-4-ylpurin-6-amine | IC50 | 44.0 [1] |
| Hymenialdisine Analogue 1 | IC50 | 1352.0 [1] |
| 4-(Pyridin-3-ylmethylene)-2-styryloxazol-5(4H)-one | IC50 | 10000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 7800.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 7800.0 [1] |
| 4-[3-(4-Fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine | IC50 | 230.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 7826.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| Khk-IN-1 | IC50 | 40000.0 [1] |
| 5-(4-Chlorophenyl)-N-(4-piperazin-1-ylphenyl)furan-2-carboxamide | IC50 | 30000.0 [1] |
| 2,2-Dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-1-[(1R)-1-phenylethyl]-3H-quinazolin-4-one | IC50 | 1000.0 [1] |
| 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
| N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 7800.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 7800.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 7800.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 7800.0 [1] |
| 3-Methyl-N-[6-methylsulfanyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine | IC50 | 1900.0 [1] |
| 3-[[[5-[1-(4-Methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazol-2-yl]thio]methyl]benzonitrile | IC50 | 10000.0 [1] |
| 2-(4-Fluorophenyl)-3-[2-[[(1S)-1-phenylethyl]amino]pyrimidin-4-yl]imidazo[1,2-a]pyrimidin-7-amine | IC50 | 100000.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 530.0 [1] |
| 3-[(1R)-1-[(2S,6R)-2,6-Dimethylmorpholin-4-yl]ethyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine | IC50 | 10.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 740.0 [1] |
| N-(1,3-Benzothiazol-2-yl)-3,3-diphenylpropanamide | IC50 | 2500.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 4-(Cyclopentylamino)-2-[(2-methoxyphenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 2-[2-[(4-Fluoro-2-methylphenoxy)methyl]-5-methoxypyridin-4-yl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one | IC50 | 59.0 [1] |
| 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| CID 71553154 | IC50 | 110.0 [1] |
| CID 76072859 | IC50 | 84.0 [1] |
| 4-[2-[1-(2-Diethoxyphosphorylethyl)triazol-4-yl]-5-(4-fluorophenyl)-3-methylimidazol-4-yl]pyridine | IC50 | 3100.0 [1] |
| 4-[4-[4-(4-Fluorophenyl)-1-methyl-5-pyridin-4-ylimidazol-2-yl]triazol-1-yl]benzoic acid | IC50 | 1600.0 [1] |
| 2-[4-[4-(4-Fluorophenyl)-1-methyl-5-pyridin-4-ylimidazol-2-yl]triazol-1-yl]ethanol | IC50 | 240.0 [1] |
| 4-[5-(4-Fluorophenyl)-3-methyl-2-(2H-triazol-4-yl)imidazol-4-yl]pyridine | IC50 | 202.0 [1] |
| 3-[4-[4-(4-Fluorophenyl)-1-methyl-5-pyridin-4-ylimidazol-2-yl]triazol-1-yl]benzoic acid | IC50 | 89.0 [1] |
| 2-[(2,2-Diphenylacetyl)amino]-benzothiazole | IC50 | 1960.0 [1] |
| CID 90643548 | IC50 | 104.0 [1] |
| N-[6-(Methylsulfonyl)benzothiazol-2-yl]-2-(2-thienyl)acetamide | IC50 | 2690.0 [1] |
| N-Methyl-4-(2-(piperidin-4-yl)-5-(3-(trifluoromethyl)phenyl)-1H-imidazol-4-yl)pyrimidin-2-amine | IC50 | 1400.0 [1] |
| (2R,3R,4R,5S,6R)-3-[4-[4-(4-Fluorophenyl)-1-methyl-5-pyridin-4-ylimidazol-2-yl]triazol-1-yl]-6-(hydroxymethyl)oxane-2,4,5-triol | IC50 | 439.0 [1] |
| 7-Ethynyl-2-(4-fluorophenyl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidine | IC50 | 100000.0 [1] |
| 7-[1-(2-Diethoxyphosphorylethyl)triazol-4-yl]-2-(4-fluorophenyl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidine | IC50 | 21400.0 [1] |
| 4-[2-(4-Ethynylphenyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl]-1H-pyridin-2-one | IC50 | 19900.0 [1] |
| 4-[5-(4-Fluorophenyl)-2-[4-[1-(2-hydroxyethyl)triazol-4-yl]phenyl]-1H-imidazol-4-yl]-1H-pyridin-2-one | IC50 | 17900.0 [1] |
| Ethyl 2-[4-[4-[5-(4-fluorophenyl)-4-(2-oxo-1H-pyridin-4-yl)-1H-imidazol-2-yl]phenyl]triazol-1-yl]acetate | IC50 | 24500.0 [1] |
| 4-[2-[4-[1-(2-Diethoxyphosphorylethyl)triazol-4-yl]phenyl]-5-(4-fluorophenyl)-1H-imidazol-4-yl]-1H-pyridin-2-one | IC50 | 44300.0 [1] |
| 4-[5-(4-Fluorophenyl)-2-piperidin-4-yl-1H-imidazol-4-yl]-1H-pyridin-2-one | IC50 | 12000.0 [1] |
| 4-[2-(4-Ethynylphenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-2-methylsulfanylpyrimidine | IC50 | 66300.0 [1] |
| N-[2-(1,3-Benzothiazol-2-ylamino)-2-oxoethyl]benzamide | IC50 | 7290.0 [1] |
| 4-[4-[3-[4-[(Propan-2-ylamino)methyl]anilino]-1H-pyrazol-5-yl]phenyl]benzene-1,3-diol | IC50 | 6340.0 [1] |
| N-(6-Ethoxy-1,3-benzothiazol-2-yl)-2,2-diphenylacetamide | IC50 | 2820.0 [1] |
| 3-Amino-1-methyl-6-[4-(4-methylpiperazin-1-yl)phenyl]-5H-pyrazolo[4,3-c]pyridin-4-one | IC50 | 39000.0 [1] |
| 4-[5-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-1H-imidazol-4-yl]-1H-pyridin-2-one | IC50 | 19700.0 [1] |
| Sodium;5-[5-(4-fluorophenyl)-4-(2-oxo-1H-pyridin-4-yl)-1H-imidazol-2-yl]-2-hydroxybenzoate | IC50 | 21200.0 [1] |
| 4-[4-(4-Fluorophenyl)-5-(2-methylsulfanylpyrimidin-4-yl)-1H-imidazol-2-yl]phenol | IC50 | 5960.0 [1] |
| N-(1,3-Benzothiazol-2-yl)-3-(3-chlorophenyl)propanamide | IC50 | 3580.0 [1] |
| N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-2-(4-methylpiperazin-1-yl)-9-pyridin-3-ylpurin-6-amine | IC50 | 700.0 [1] |
| N-[(6-Methoxy-1H-benzimidazol-2-yl)methyl]-2-piperazin-1-yl-9-pyridin-3-ylpurin-6-amine | IC50 | 625.0 [1] |
| N-[(6-Methoxy-1H-benzimidazol-2-yl)methyl]-2-morpholin-4-yl-9-pyridin-3-ylpurin-6-amine | IC50 | 520.0 [1] |
| 6-N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-N-(3-morpholin-4-ylpropyl)purine-2,6-diamine | IC50 | 915.0 [1] |
| 6-N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)purine-2,6-diamine | IC50 | 55.0 [1] |
| N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-9-(4-fluorophenyl)-2-morpholin-4-ylpurin-6-amine | IC50 | 535.0 [1] |
| 9-(3-Fluorophenyl)-2-morpholin-4-yl-N-[(5-phenyl-1H-imidazol-2-yl)methyl]purin-6-amine | IC50 | 215.0 [1] |
| 9-(3-Fluorophenyl)-N-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]methyl]-2-morpholin-4-ylpurin-6-amine | IC50 | 50.0 [1] |
| N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-2-(1,1-dioxo-1,4-thiazinan-4-yl)-9-(3-fluorophenyl)purin-6-amine | IC50 | 175.0 [1] |
| N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-9-(2,4-difluorophenyl)-2-morpholin-4-ylpurin-6-amine | IC50 | 525.0 [1] |
| N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-2-(4-methylpiperazin-1-yl)-9-(2-methylpyridin-4-yl)purin-6-amine | IC50 | 295.0 [1] |
| 6-N-[(4,5-Difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-N-(2-morpholin-4-ylethyl)purine-2,6-diamine | IC50 | 830.0 [1] |
| N-(1H-Benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-pyridin-3-ylpurin-6-amine | IC50 | 1155.0 [1] |